Caris Life Sciences, Inc. (CAI)
NASDAQ · Healthcare
Caris Life Sciences, Inc. Operating Income 2023–2025
Caris Life Sciences, Inc. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Caris Life Sciences, Inc. operating income for the quarter ending March 31, 2026 was 5.3 M, a 109.11% decrease year-over-year.
- Caris Life Sciences, Inc. operating income for the twelve months ending March 31, 2026 was -38.0 M.
- Caris Life Sciences, Inc. annual operating income for 2025 was 45.1 M, a 117.55% decrease from 2024.
- Caris Life Sciences, Inc. annual operating income for 2024 was -257.1 M, a 19.54% decrease from 2023.
- Caris Life Sciences, Inc. annual operating income for 2023 was -319.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Caris Life Sciences, Inc. Operating Income — FAQ
Caris Life Sciences, Inc. (CAI) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Caris Life Sciences, Inc.'s operating income?
Caris Life Sciences, Inc. (CAI) reported operating income of $45M for fiscal 2025.
Where can I see CAI's operating income history?
The chart and table above show Caris Life Sciences, Inc.'s operating income by year and by quarter, including the growth rate.